Life Science News

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, announces the appointment of Giovanni Garay as Ontario General Manager, effective immediately.

"We are very excited to have Giovanni join Premier Health. His hiring follows our recent acquisition in Ontario, and he will be an important member of the Corporation's senior leadership team," said Martin Legault, Chief Executive Officer. "Giovanni's experience with large organisations will benefit Premier Health as we continue to expand our footprint in the province." he added.

Giovanni is a seasoned professional that has demonstrated strong abilities in delivering industry-leading service standards and measurable performance improvements in fast paced environments. He has held several leadership roles with Scotia Bank, Cap Gemini, and ADP and has developed over the years an expertise in managing strategic initiatives including quality framework, training, and coaching programs, as well as client relationship management. Giovanni is a strong change agent and uses coaching and mentoring to transform teams into high performers, positively impacting organizational culture and effectiveness, and associate development with results in meeting and exceeding corporate objectives. Giovanni is a Natural leader and persuasive communicator with the ability to forge strong relationships across levels and functions.

About Premier Health

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper and more accessible care services.

For Further Information Please Contact:

Mr. Jean-Robert Pronovost
Vice-President, Corporate Development
Premier Health of America Inc.
jrpronovost@premierhealth.ca / 1 800 231 9916

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com.



Primary Logo

News Provided by GlobeNewswire via QuoteMedia

PHA:CA
Premier Health of America

Premier Health of America


Keep reading... Show less
Premier Health Reports FY2022 Second Quarter Results

Premier Health Reports FY2022 Second Quarter Results

Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its second quarter ended March 31, 2022.

Summary

Keep reading... Show less
Premier Health Announces Grant of Options and Deferred Share Units

Premier Health Announces Grant of Options and Deferred Share Units

Premier Health of America Inc. (TSXV: PHA ) (" Premier Health " or the " Corporation ") announces the grant of 1,090,000 stock options to certain officers and employees of the Corporation. These stock options are granted in accordance with the terms of the stock option plan of the Corporation. All options fully vest on September 30, 2022, and each option entitles the holder thereof to purchase one (1) common share of the Corporation at a price of $0.80 per common share for a period of five (5) years from April 11, 2021. The Corporation also announces that it has granted an aggregate of 664,000 deferred share units (" DSUs ") to six directors of the Corporation. The DSUs are payable in common shares of the Corporation upon the holder ceasing to be a director of the Corporation.

About Premier Health

Keep reading... Show less
Premier Health Completes the Previously Announced Acquisition of Canadian Health Care Agency

Premier Health Completes the Previously Announced Acquisition of Canadian Health Care Agency

Premier Health of America Inc. (TSXV: PHA ) (" Premier Health " or the " Corporation "), a leading Canadian Healthtech company, is pleased to announce that it has completed the acquisition of 100% of the outstanding shares of Umana Holdings Inc. (" Umana ") and its wholly-owned subsidiary Canadian Health Care Agency (" CHCA "), through a newly created wholly owned federally incorporated subsidiary, 13822214 Canada (" CanCo "), for a total consideration comprised between C$10.5M to C$14.5M (the " Purchase Price "), payable in cash, depending on the achievement of performance objectives (the " Transaction "), minus indebtedness, as more fully detailed below. As a result of the Transaction and a corporate reorganization, CHCA became a wholly owned subsidiary of the Corporation. The Corporation will continue the business of CHCA which consists in providing specialized nursing services.

"The acquisition of CHCA starts our expansion outside of the province of Quebec and consolidates our market position in Canada's northern regions" Said Martin Legault, CEO of Premier Health. " In addition, the Cambridge based agency provides us with a good management infrastructure in Ontario that will serve as a base to continue our expansion in this province. This is a strategy we are expecting to follow in other provinces as well."

Keep reading... Show less
Premier Health Enters Into Binding Agreement to Acquire Leading Ontario Agency Canadian Health Care Agency

Premier Health Enters Into Binding Agreement to Acquire Leading Ontario Agency Canadian Health Care Agency

Premier Health of America Inc. (TSXV: PHA ) (" Premier Health " or the " Corporation "), a leading Canadian Healthtech company, is pleased to announce that it has entered this day into a share purchase agreement (the " SPA ") to acquire, through a newly created wholly owned federally incorporated subsidiary, 13822214 Canada (" CanCo "), 100% of the outstanding shares of Umana Holdings Inc. (" Umana ") and its wholly-owned subsidiary Canadian Health Care Agency, (" CHCA ") for a total consideration comprised between C$10.5M to C$14.5M (the " Purchase Price "), payable in cash, depending on the achievement of performance objectives (the " Transaction "), minus indebtedness, as more fully detailed below. As a result of the Transaction and a corporate reorganization, CHCA will become a wholly owned subsidiary of the Corporation. The Corporation will continue the business of CHCA which consists in providing specialized nursing services.

"The acquisition of CHCA starts our expansion outside of the province of Quebec and consolidates our market position in Canada's northern regions" Said Martin Legault, CEO of Premier Health. " In addition, the Cambridge based agency provides us with a good management infrastructure in Ontario that will serve as a base to continue our expansion in this province. This is a strategy we are expecting to follow in other provinces as well."

Keep reading... Show less

Viemed Healthcare to Host Investor Webcast

Viemed Healthcare, Inc. (the " Company " or " Viemed ") (NASDAQ:VMD and TSX:VMD.TO), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, announced that it will host a webcast investor presentation on Thursday, June 2 nd 2022 at 2:00 PM ET.

During the webcast, Casey Hoyt, CEO, and Todd Zehnder, COO, will conduct a presentation that will cover key areas of Viemed's business. After the formal presentation, investors will have an opportunity to ask questions through an interactive Q&A portal.

Keep reading... Show less

Medtronic reports full year and fourth quarter fiscal year 2022 financial results; announces 8% dividend increase

Mid-single digit FY22 revenue growth; Q4 results affected by temporary global supply chain impacts and China lockdowns

Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2022, which ended April 29, 2022 .

Keep reading... Show less

Medtronic and DaVita announce New Kidney Health Technology Company

Companies join forces to accelerate kidney care device innovation and improve patient outcomes

Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) today announced the intent to form a new, independent kidney care-focused medical device company ("NewCo" or "the Company") to enhance the patient treatment experience and improve overall outcomes.

Keep reading... Show less

Medtronic and DaVita announce new kidney health technology company

Companies join forces to accelerate kidney care device innovation and improve patient outcomes

Medtronic plc (NYSE:MDT) and DaVita Inc. (NYSE:DVA) today announced the intent to form a new, independent kidney care-focused medical device company ("NewCo" or "the Company") to enhance the patient treatment experience and improve overall outcomes.

Keep reading... Show less

INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Abbott Laboratories' Directors and Officers for Breach of Fiduciary Duties - ABT

Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is investigating whether certain directors and officers of Abbott Laboratories ("Abbott") (NYSE: ABT) breached their fiduciary duties to Abbott and its shareholders. If you are an Abbott shareholder, you are encouraged to contact attorney Joe Pettigrew with Scott+Scott for additional information at (844) 818-6982 or jpettigrew@scott-scott.com .

Scott+Scott is investigating whether members of Abbott's board of directors or senior management failed to manage Abbott in an acceptable manner, in breach of their fiduciary duties to Abbott, and whether Abbott and its shareholders have suffered damages as a result.

Keep reading... Show less

Abbott to Release EleCare® Amino Acid-based Formulas to Help Meet Critical Patient Need

  • Abbott to release limited quantities of EleCare ® branded specialty formulas
  • Product will be released immediately free of charge to children in need
  • Parents and caregivers in urgent need should contact their healthcare professionals or Abbott at +1-800-881-0876 for additional information
  • Abbott plans to restart production at the Sturgis facility on June 4 and will prioritize EleCare production, with initial EleCare product release to consumers beginning on or about June 20

Abbott (NYSE: ABT) today announced that the U.S. District Court for the Western District of Michigan has amended the recent consent decree allowing Abbott to release limited quantities of its EleCare ® specialty amino acid-based formulas that were previously on hold following the Feb. 17 recall of some powder infant formulas from its Sturgis, Mich. facility. The consent decree was amended at the request of Abbott and the U.S. Food and Drug Administration (FDA) to enable the company to get EleCare to children in urgent medical need. These EleCare product batches were on hold pursuant to an agreement with the FDA.

All products have been tested and meet all product release requirements. In addition, Abbott has concluded additional, enhanced testing to provide assurance the product is safe to distribute. Abbott plans to restart production at the Sturgis facility on June 4 and will prioritize EleCare production, with initial EleCare product release to consumers beginning on or about June 20 .

Keep reading... Show less

Latest Press Releases

Related News

×